Memantine Medications

Memantine (often recognised by the brand Ebixa) is a medication utilized in the management of Alzheimer’s Disease. It helps regulate brain activity to address cognitive and functional decline. This catalogue centralises the available product, Namenda, for patients seeking this treatment option across Indonesia and Hong Kong.

Medicine containing Memantine

Namenda

Alzheimer's Disease

5 · 10mg

Intended to target cognitive decline in Alzheimer's disease, this medication is designed to support mental function and alleviate symptoms of moderate to severe dementia.

From $0.62 / tablet View

What is Memantine?

Memantine is a pharmaceutical in the Neurology group. It is specifically used to address symptoms associated with moderate to severe cognitive impairment. By regulating the activity of neurotransmitters in the brain, it supports daily function for individuals managing specific degenerative conditions.

How does Memantine work?

Excessive activity of a brain chemical called glutamate is linked to cell damage in neurodegenerative conditions. Memantine functions as an NMDA receptor antagonist, which acts to block the overstimulation of these receptors. This mechanism helps to stabilise brain function and may assist with maintaining cognitive abilities.

Memantine brands and forms

The primary format for this medication is the film-coated tablet. These are designed for consistent release, allowing for established dosing protocols. While variations exist in manufacturing, the active ingredient remains standard across the available product listed here, comparing originator brands like Ebixa against available generic formulations.

Buying Memantine online in Indonesia and Hong Kong

Accessing Memantine across Indonesia and Hong Kong is straightforward when comparing established brands like Namenda. Ordering online allows for convenient delivery, providing reliable access to this essential treatment. This service extends to various other Asian markets including Taiwan, Vietnam and South Korea, ensuring patients have consistent options for their healthcare needs.

Safety overview for Memantine

What to check before using this medicine

Use requires an assessment of kidney and liver health, as these organs are primarily responsible for clearing the medication from the body. Individuals with a history of seizure disorders or recent cardiovascular conditions need to be monitored.

Possible reactions and tolerability

Common reactions can include dizziness, headache, or confusion. Some individuals may experience constipation or elevated blood pressure. These effects are often dependent on the dosage and individual tolerance.

Interactions and health factors

Avoid combining this medication with other NMDA antagonists or specific medicines that increase urine pH, as these may alter how the body processes the active ingredient. Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.

Important safety information for Memantine

This is an educational overview, not medical advice. Products differ in formulation, strength and directions. This page does not authorise clinical application or unsupervised use. Review individual product labelling and speak with a healthcare professional when clinical judgement is needed regarding your specific condition or treatment plan.